neostigmine has been researched along with Sicca Syndrome in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DEHAAS, EB | 1 |
| Portacha, L | 1 |
2 other studies available for neostigmine and Sicca Syndrome
| Article | Year |
|---|---|
THE RESPONSE OF THE LACRIMAL GLAND TO PARASYMPATHICOMIMETICS IN KERATOCONJUNCTIVITIS SICCA.
Topics: Drug Therapy; Dry Eye Syndromes; Humans; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Methacholin | 1964 |
[Our experience with the treatment of ocular changes in Sjögren's syndrome].
Topics: Administration, Oral; Aged; Alcohols; Bromhexine; Female; Formaldehyde; Humans; Middle Aged; Neostig | 1984 |